eHealth stock reports a 45 percent revenue decline in Q2

eHealth stock reported second-quarter 2026 revenue of USD 33.6 million, down 45 percent from the prior-year period, while the shares were last at USD 0.76 on Nasdaq on October 6, 2026, up 11.45 percent. The latest operating picture combines a sharp revenue contraction with a restructuring plan aimed at improving cash generation.

Revenue fell as strategy changed

According to Yahoo Finance in the August 4, 2026 earnings transcript, second-quarter revenue was USD 33.6 million and adjusted EBITDA was negative USD 21.8 million. Total commission revenue reached USD 29.8 million, including USD 7.6 million of net adjustment revenue, compared with USD 17.8 million a year earlier.

The revenue decline was linked to lower enrollment volume and deliberate reductions in marketing outside the main enrollment periods. Medicare segment revenue fell 45 percent to USD 31.8 million, while Medicare submissions declined 44 percent, making the upcoming annual enrollment period central to the company's near-term operating performance.

Losses widened despite cost cuts

GAAP net loss increased to USD 23.6 million in Q2 2026 from USD 17.4 million in Q2 2025. Adjusted EBITDA loss also widened to USD 21.8 million from USD 14.1 million, although non-GAAP operating expenses declined 25 percent to USD 58.6 million, according to Yahoo Finance.

Cash flow offered a counterpoint to the earnings loss. Operating cash flow for the first six months of 2026 was USD 30.8 million, while second-quarter operating cash flow was negative USD 5.0 million versus negative USD 41.2 million in the prior-year quarter. Management also maintained its 2026 guidance ranges and updated net adjustment revenue guidance to USD 16 million-20 million.

Stock remains near its yearly low

EHTH's October 6, 2026 trading range was USD 0.69 to USD 0.76, against a 52-week range of USD 0.65 to USD 5.89. The USD 24.1 million market capitalization leaves the stock highly sensitive to enrollment trends, cash flow execution and the success of the lifetime advisory model.

The company is using the model to shift from one-time enrollment interactions toward recurring member engagement and ancillary product sales. The earnings transcript says second-quarter ancillary cross-sell rates doubled from a year earlier, while management expects sustainable revenue growth to begin in 2027.

eHealth stock was last at USD 0.76

eHealth stock was last at USD 0.76 on Nasdaq on October 6, 2026 at 4:00 p.m. ET, up 11.45 percent from the prior close of USD 0.68. The primary listing and ISIN US28238P1093 are identified for EHTH by MarketScreener.

More news and analysis on eHealth stock